Modifying Antimicrobial Peptides with Albumin-Binding Molecules Enhances Membrane-Disrupting Efficacy by Modulating...

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Antimicrobial peptides (AMPs) show promise against drug-resistant bacteria but face challenges in clinical use due to poor pharmacokinetics and low efficacy.
• Existing AMPs often exhibit suboptimal stability and systemic toxicity, limiting their therapeutic potential.

Purpose of the Study:

• To enhance the antimicrobial activity and biosafety of AMPs through modification with albumin-binding molecules (ABMs).
• To investigate the dual mechanism of structural stabilization and albumin-mediated pharmacokinetic improvement in modified AMPs.

Main Methods:

• Modification of two model AMPs with ABMs.
• Assessment of secondary structure stabilization and bacterial membrane disruption.
• In vivo pharmacokinetic studies and vascular toxicity assessments.
• Molecular dynamic simulations and experimental validation of AMP-mediated membrane disruption mechanisms.

Main Results:

• ABM modification stabilized AMP secondary structures, enhancing bacterial membrane disruption.
• Modified AMPs exhibited reduced renal clearance due to albumin binding, improving in vivo pharmacokinetics.
• Albumin binding minimized AMP interaction with blood and endothelial cells, reducing vascular toxicity without compromising antimicrobial efficacy.

Conclusions:

• Albumin-binding molecule modification offers a versatile strategy to overcome AMP limitations, improving both efficacy and safety.
• The dual mechanism of structural stabilization and enhanced pharmacokinetics presents a promising approach for developing potent and systemically safe antimicrobial therapies.